Netherlands· NL-54e291738723
Actokit D, combinatieverpakking
A risedronsäure, calcium und colecalciferol, sequenzialpräparate product containing calciumcarbonaat (e 170) + cholecalciferol + natriumrisedronaat 2,5-water + risedroninezuur, registered in Netherlands by Theramex Ireland Limited. The same ATC class is registered in 3 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Risedronsäure, calcium und colecalciferol, sequenzialpräparate is registered in 3 of 19 countries.
Countries holding a registration under ATC M05BB04 (risedronsäure, calcium und colecalciferol, sequenzialpräparate), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 2 of them publish a price we can compare per daily dose
Risedronsäure, calcium und colecalciferol, sequenzialpräparate · ATC M05BB04
3 / 19 countries
- Belgiumprice
- Finlandprice
- Netherlands
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- CALCIUMCARBONAAT (E 170) + CHOLECALCIFEROL + NATRIUMRISEDRONAAT 2,5-WATER + RISEDRONINEZUUR
- Manufacturer
- Theramex Ireland Limited
- Country
- Netherlands (NL)
- ATC code
- M05BB04
- ATC class
- Risedronsäure, Calcium und Colecalciferol, Sequenzialpräparate
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id34894
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under M05BB04
Risedronsäure, calcium und colecalciferol, sequenzialpräparate, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/574bbcbc-a469-4f0e-a55f-e19cfa15a02f GET /v1/drugs/574bbcbc-a469-4f0e-a55f-e19cfa15a02f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Bruisgranulaat, Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h34894_smpc.pdf",
"strength": null,
"atc_label": "Risedronic Acid, Calcium And Colecalciferol, Sequential",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg34894",
"excipients": [
"APPELZUUR, (L-)(-)(E 296)",
"ARABISCHE GOM (E 414)",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CITROENSMAAKSTOF",
"CITROENZUUR 0-WATER (E 330)",
"COPOLYMEER VAN ETHYLACRYLAAT-METHACRYLZUUR (1:1)",
"DEXTRINE",
"DINATRIUMEDETAAT 2-WATER",
"GELATINE (E 441)",
"GLUCONOLACTON (E 575)",
"GLUCONOLACTON (E 575)",
"IJZEROXIDE GEEL (E 172)",
"KALIUMCARBONAAT 0-WATER (E 501)",
"MAGNESIUMSTEARAAT (E 470b)",
"MALTODEXTRINE",
"MANNITOL (D-) (E 421)",
"MAÏSZETMEEL",
"NATRIUMCYCLAMAAT (E 952)",
"NATRIUMZETMEELGLYCOLAAT",
"POLYSORBAAT 80 (E 433)",
"RIJSTZETMEEL",
"SACCHAROIDE NATRIUM X-WATER (E 954)",
"SACCHAROSE",
"SILICIUMDIOXIDE (E 551)",
"SIMETICON",
"SOJABOONOLIE, GEHYDREERD (E 479b)",
"SORBITOL (E 420)",
"STEARINEZUUR (E 570)",
"TALK (E 553b)",
"TOCOFEROL, DL-ALFA (E 307)",
"TRIETHYLCITRAAT (E 1505)"
],
"substances": [
"CALCIUMCARBONAAT (E 170)",
"CHOLECALCIFEROL",
"NATRIUMRISEDRONAAT 2,5-WATER",
"RISEDRONINEZUUR"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h34894.pdf",
"authorised_at": "2007/07/24",
"procedure_number": "SE/H/0732/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "34894",
"additional_monitoring": "N"
}See everything about risedronsäure, calcium und colecalciferol, sequenzialpräparate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.